University of Thessaly (UTH)
Ανταπόκριση στη θεραπεία με αντιβιοτικά τελευταίας εκλογής λοιμώξεων σε πειραματόζωα (επίμυες, μύες, κονίκλους) από πολυανθεκτικά μικρόβια
Abstract
dc:descriptionWith this study, we tried to fill a gap in bibliography in relevance with successful treatment schemes against MDR bacteria that relied till now in in vitro studies. Specifically, we studied OS-MRSA isolates and we investigated the efficacy of dicloxacillin and compared to vancomycin. Also we investigated the in vivo activity of antibiotics in monotherapy and in combinations against KPC-producing Enterobacteriaceae. We used tigecycline, rifampin, colistin, meropenem and gentamicin. We used isolates that were susceptible in meropenem even they produce carvapenemases. At the end, we investigated the activity of meropenem against clinical isolates of A. baumannii that show heterogenicity.In particular, the activity of dicloxacillin for the treatment of experimental thigh infections was similar to that of vancomycin in 8 OS-MRSA (66.7%), while vancomycin was more efficient in 7 isolates (75%). The favorable response to dicloxacillin treatment in a considerable proportion of OS-MRSA may have significant implications for the treatment of OS-MRSA infections.The results of the experimental infections suggested that heterogeneously grown A. baumannii subpopulations have lower virulence compared with the clinical isolates, as 9/15 untreated animals infected by persisters or heteroresistant subpopulations survived, while all untreated mice infected by clinical isolates died. The lower virulence of the phenotypic heterogeneous subpopulations is also reflected by the observation that the lowest meropenem dosage conferred survival of 14/15 mice infected by persisters or heteroresistant subpopulations in contrast with only 7/15 mice infected by clinical isolates to survive. Finally, the infection outcome under meropenem treatment was overall not correlated with the meropenem MICs, even in stably resistant heterogeneous populations, further suggesting their impaired virulence.Our in vivo results indicate that tigecycline alone had the best activity compared to all other antibiotics, followed by rifampin. Gentamicin, meropenem and colistine alone clearly underperformed. Tigecycline+rifampin improved significantly tigecycline activity in most isolates, followed by tigecycline+gentamicin. Tigecycline+colistine did not ameliorate considerably tigecycline activity. T igecycline+meropenem showed antagonism in 4/9 isolates after both 24 and 48h treatment, which was significant in 2 cases
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Michail, Georgios
- Μιχαήλ, Γεώργιος
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/29239